axi-cel in patients with r/r lbcl in complete metabolic response
Published 1 year ago • 74 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
1:11
insights into real-world outpatient administration of axi-cel and brexu-cel in r/r nhl
-
2:05
cd58 aberrations correlate with poor response to axi-cel in lbcl
-
32:56
echo analyzer monthly maintenance
-
6:28
cytoquest™ cr ctc enrichment - rbc lysis
-
5:54
day in the life - haematology - dr ellen maxwell
-
3:33
a novel composite endpoint of toxicity and pfs in patients with r/r fl treated with axi-cel
-
1:21
approval of axi-cel in second-line for r/r lbcl & label update
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
2:52
zuma-24 preliminary analysis of axi-cel in the outpatient setting in patients with r/r lbcl
-
2:26
zuma-5: high orr and cr for r/r inhl with axi-cel
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
1:22
safety and efficacy of cc-99282 in the treatment of r/r nhl
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:51
thrombotic and bleeding complications in al amyloidosis
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:57
investigating the efficacy and safety of adct-602 in patients with r/r b-all
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸